Low Vision Month: Treatment of Macular Degeneration

Blog vol 4.34. Low Vision Month: Treatment of Macular Degeneration


There is much cause for celebration here. In the early 90’s, we were looking at a whole bunch of elderly people having “senile” macular degeneration in the next 20-30 years. I went to Waterloo for a Low Vision Residency to prepare for the deluge. Thankfully the deluge did not happen. A combination of many factors resulted in a milder “version” of what we now call age-related macular degeneration (ARMD). People reduced their smoking, improved their diets, started exercising, started taking antioxidants like lutein, and received cutting-edge diagnosis and treatment.


Now in 2024, we have anti-VGEf treatments that reduce bleeding around the macula.  We now also have very precise and complete imaging with optical coherence tomography (OCT) and swept-source tomography to simulate angiography (OCTA) to help detect, track, and treat the disease. In 2009 we got our first OCT machine and have never looked back. In 2016 we started doing OCTs on everyone over 20, a great screening tool for all sorts of conditions. Then in 2019, we donated the original OCT to a clinic in Ghana and moved up to OCTA imaging. 


The OCTA is our best tool. We also screen for family history, and other cardiovascular conditions, and encourage people to stop smoking (or Vaping). The numbers have really come down, and the severity of the vision loss has been greatly reduced, with most people continuing to have somewhat “normal” lives even with visual impairment.


With the advancements in Anti-VGEf injections and the introduction of Vabysmo (pronounced Vah-BYES-moh) into Canada, it is possible to extend the space between treatments up to six months instead of every two months.  And now with the latest development in the U.S. of injections of Syfovre and Izervay for Geographic Atrophy which, up to this point, was untreatable and devastating, there is hope also on this front. And a ways down the road, there is promise in the Waterloo research into Wnt genes which work with stem cells for wet ARMD.


On the more functional side, the ability to drive with bioptics in Ontario, the development of electronic magnifiers, and Artificial intelligence apps all are new helps for the visually impaired. 


Please get your eyes checked, especially if you are in your 30’s and 40’s, to catch problems early. As always, prevention, prevention.  Many conditions can be treated. Early detection = better vision for life. 


     

Til next week,


 

The good doctor


By Dr. Mark Germain May 7, 2026
The good doctor admires the wonders of the Osprey's vision.
By Dr. Mark Germain May 1, 2026
The good doctor discusses how the eye is a window to the heart with the help of the OCT.
The good doctor take a deeper look at how gut health is connected to eye tissues.
By Dr. Mark Germain April 29, 2026
Blog vol 6.40. The Gut and the Eyes. One of my biggest jobs is to keep abreast of new research and advances in eye health. Most recently, we have seen new stem cell research, gene therapies, as well as new drugs for dry and wet macular degeneration. In January of this year, there was an article in the journal, Cell Death and Disease, that looked at cell apoptosis, specifically with the photoreceptors of the eye. (Read the article here ). Apoptosis is the genetic programming of deliberate and constructive cell death, allowing for the maintenance of healthy structures and systems in the body. Some estimates have the body replacing 50 to 70 billion cells daily by this process. Necrosis, on the other hand, is unplanned cell death caused by injury, toxins, or other negative outside factors; this causes inflammation and disrupts the body’s balance of things. There are stressors that speed up cell turnover. The study looked at photoreceptors in the retina and were able to demonstrate cellular recovery, even in late stages of apoptosis, recovery not breakdown. When certain stressors were reduced, by working with the mitochondria, there was recovery of the photoreceptor cells. How? Mitophagy, the mitochondria’s own process of programmed breaking down and then repurposing the recycled components for new ones. This mitochondrial repair helps to reverse the sequence of apoptosis for the photoreceptors. Mitochondria, how cool. How is this helpful for our eyes? Conditions like retinitis pigmentosa or macular degeneration directly involve the photoreceptors and may be slowed or reversed by helping the mitochondria. So, let’s take care of those mitochondria. There is some evidence for nutritional support for the mitochondrial system. The nutrient, Urolithin A (UA), which is a compound made in our gut from fiber found in pomegranates, berries, and nuts is the only clinically proven substance known to trigger mitophagy, made in the gut no less. Vitamin B3 is critical for mitochondria function, however vitamin B3 based supplements are still to be clinically tested for their support of cell recovery. Nutrients Coenzyme Q10 and L-carnitine are known to help the mitochondria generate energy, and interestingly, infrared light therapy has also been shown to benefit mitochondrial function. Again, food for thought. The gut and its function needs a lot of research. How do probiotics and nutrient precursors affect eye tissues? It is so interesting that the gut can be a factor in eye health. Maybe adding Urolithin A as a supplement is wise, along with the antioxidants in Lutein and Zeaxanthin we use to combat photoreceptor degeneration. Will keep you posted on any new developments.  The good doctor
By Dr. Mark Germain April 16, 2026
The good doctor focuses in on visual processing. Why do we miss things that are right in front of our eyes?
By Dr. Mark Germain April 10, 2026
The good doctor discusses the Artemis II mission, space travels affects on the eyes, and "the dark side of the moon"
By Dr. Mark Germain April 3, 2026
The good doctor discusses exciting new and emerging options to treat nystagmus.
More Posts